Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,011,410
+$128,511 QoQ
Shares Held
15,653
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,588
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Wealth Partners, LLC holds $8,124,213 across 7 Drug Manufacturers - General names. MRK ranks #2 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,396 | $3,402,182 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
15,653 | $2,011,410 | |
| 3 | ABBV |
AbbVie Inc.
|
3,699 | $930,816 | |
| 4 | PFE |
Pfizer Inc
|
21,656 | $521,476 | |
| 5 | AMGN |
Amgen Inc
|
1,372 | $496,828 | |
| 6 | LLY |
ELI LILLY & Co
|
331 | $397,011 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,885 | $364,490 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,011,410 | 15,653 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,882,899 | 15,653 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,314,697 | 12,490 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $1,048,201 | 12,489 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $988,550 | 12,488 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,120,743 | 12,486 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,242,007 | 12,485 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,417,796 | 12,485 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,545,519 | 12,484 | Shares | Sole | 2024-09-11 | |
| 2024-03-31 | $1,647,131 | 12,483 | Shares | Sole | 2024-09-11 | |
| 2023-12-31 | $1,347,051 | 12,356 | Shares | Sole | 2024-09-11 | |
| 2023-09-30 | $1,303,141 | 12,658 | Shares | Sole | 2024-09-11 | |
| 2023-06-30 | $1,446,067 | 12,532 | Shares | Sole | 2024-09-11 | |
| 2023-03-31 | $1,333,173 | 12,531 | Shares | Sole | 2024-09-11 | |
| 2022-12-31 | $1,390,314 | 12,531 | Shares | Sole | 2024-09-11 | |
| 2022-09-30 | $1,100,269 | 12,776 | Shares | Sole | 2024-09-11 | |
| 2022-06-30 | $1,043,258 | 11,443 | Shares | Sole | 2024-09-11 | |
| 2022-03-31 | $938,816 | 11,442 | Shares | Sole | 2024-09-11 | |
| 2021-12-31 | $876,838 | 11,441 | Shares | Sole | 2024-09-10 | |
| 2021-09-30 | $859,333 | 11,441 | Shares | Sole | 2024-09-10 | |
| 2021-06-30 | $889,688 | 11,440 | Shares | Sole | 2024-09-10 | |
| 2021-03-31 | $885,687 | 11,489 | Shares | Sole | 2024-09-10 | |
| 2020-12-31 | $954,850 | 11,673 | Shares | Sole | 2024-09-10 | |
| 2020-09-30 | $961,059 | 11,586 | Shares | Sole | 2024-09-10 | |
| 2020-06-30 | $905,844 | 11,714 | Shares | Sole | 2024-09-10 | |
| 2020-03-31 | $894,273 | 11,623 | Shares | Sole | 2024-09-10 | |
| No filing history on record for this holder in this stock. | ||||||